1. Home
  2. NNDM vs CAPR Comparison

NNDM vs CAPR Comparison

Compare NNDM & CAPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nano Dimension Ltd.

NNDM

Nano Dimension Ltd.

SELL

Current Price

$1.19

Market Cap

606.7M

Sector

Technology

ML Signal

SELL

Logo Capricor Therapeutics Inc.

CAPR

Capricor Therapeutics Inc.

SELL

Current Price

$8.30

Market Cap

584.9M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
NNDM
CAPR
Founded
2012
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
606.7M
584.9M
IPO Year
2015
2011

Fundamental Metrics

Financial Performance
Metric
NNDM
CAPR
Price
$1.19
$8.30
Analyst Decision
Buy
Analyst Count
0
10
Target Price
N/A
★ $27.25
AVG Volume (30 Days)
1.2M
★ 3.6M
Earning Date
11-05-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
★ N/A
N/A
Revenue
★ $102,437,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$6.00
$85.77
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 77.30
N/A
52 Week Low
$1.19
$2.96
52 Week High
$2.32
$40.37

Technical Indicators

Market Signals
Indicator
NNDM
CAPR
Relative Strength Index (RSI) 28.94 50.24
Support Level N/A $7.78
Resistance Level $1.62 $10.42
Average True Range (ATR) 0.06 1.01
MACD -0.01 0.23
Stochastic Oscillator 4.53 45.99

Price Performance

Historical Comparison
NNDM
CAPR

About NNDM Nano Dimension Ltd.

Nano Dimension Ltd provides industrial manufacturing solutions for the design-to-manufacturing of electronics and mechanical parts. These solutions are based on a combination of hardware, software, and materials science technologies. The solutions include industrial machinery, such as those for additive manufacturing, surface-mount technology, and industrial inkjet printing, along with software for design, simulation, and manufacturing management, as well as materials or consumables that are used by the machinery. These solutions are used by industrial customers in aerospace & defense, automotive, electronics, medical, research, and academia, along with government organizations.

About CAPR Capricor Therapeutics Inc.

Capricor Therapeutics Inc is a clinical-stage biotechnology company focused on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (DMD), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with high unmet medical needs. The company's product pipeline includes CAP-1002, deramiocel an allogeneic cardiac-derived cell therapy. Deramiocel is currently advancing through Phase 3 clinical development for the treatment of Duchenne muscular dystrophy. Through its proprietary StealthXTM platform, the group uses its exosome technology to conduct preclinical research focused on vaccinology, delivering oligonucleotides, proteins, and small molecules to treat.

Share on Social Networks: